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Allergic rhinitis (AR) is a relevant risk factor for the development of asthma in children. We recruited a cohort of 104
children with AR and re-evaluated them after 5 years. We considered the ARIA classification. All patients, who had
moderate to severe persistent AR at baseline, developed asthma symptoms. These results strongly indicate that the
severity of AR may be an important factor that increases the risk of asthma development in children.
Keywords: Allergic rhinitis, Asthma, Severity, ChildrenIntroduction
Allergic rhinitis (AR) is a relevant risk factor for the de-
velopment of asthma in children and is an important
trigger factor for exacerbations in patients with asthma
[1]. Moreover, AR and asthma are closely associated
both from a pathophysiological and a clinical point of
view [2]. AR frequently may precede asthma insomuch as
it has been proposed the term “asthma march” to define
the progression from AR towards asthma [3].
AR is presently classified as intermittent or persistent
on the basis of the symptoms duration according to
ARIA guidelines [1]. In addition, AR is classified as mild
or moderate-severe according to symptom severity.
Therefore, this study aimed to investigate whether the
ARIA classification of AR may be useful to predict the
possible development of asthma in children with AR
alone.Methods and Results
One hundred four children (51 males, mean age 8.3
years, age range 7–13) with AR were evaluated in this
prospective study. Children were recruited and visited at
the Institute of Pediatrics of the University of Perugia
(Italy).
Inclusion criteria were: age range between 6 and 14
years, documented and validated diagnosis of AR, and* Correspondence: gio.cip@libero.it
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unless otherwise stated.written informed consent signed by parents. Exclusion
criteria were, absence of sensitization, history of asthma
symptoms, impaired lung function, previous or current
specific allergen immunotherapy, and chronic diseases.
The review board approved the study. Patients were
treated with medications alone on demand.
Demographic and clinical data were recorded at base-
line and after 5-year follow-up.
At baseline, all patients were evaluated for sensitization
to inhaled allergens by skin prick test (SPT), lung func-
tion, and AR was graded according to ARIA guidelines
[1]. After 5 years, all patients were assessed for history of
asthma symptoms, according to GINA guidelines [4], and
AR severity, according to ARIA classification.
AR diagnosis was based on the consistency between
nasal symptoms history and sensitization. Asthma
diagnosis was performed on asthma symptoms his-
tory, impaired lung function, and functional testing
(mainly bronchodilation).
At baseline, all patients were sensitized to aeroaller-
gens (59 for HMD, 36 for grass pollens, and 20 for tree
pollens), 10.5% were polysensitized. Lung function was
normal in all patients, both concerning FEV1 (97.1 ± 5%
of predicted) and PEF (97.7 ± 5.1% of predicted). Ac-
cording to ARIA classification, patients were divided
into 3 groups: 74 patients with moderate-severe inter-
mittent AR (Group 1), 24 patients with mild persistent
AR (Group 2), and 6 patients with moderate-to-severe
persistent AR (Group 3), as reported in Figure 1A.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 A = number of patients with intermittent, or mild persistent or moderate-severe persistent allergic rhinitis at baseline;
B = percentage of patients with asthma at 5-year follow-up (subdivided per allergic rhinitis classification).
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asthma. Considering the ARIA classification: 5/74
(7%) patients of Group 1 developed intermittent
asthma, 8/24 (33%) patients of Group 2 had asthma
(7 intermittent and 1 mild persistent), and 6/6
(100%) patients with moderate-severe persistent AR
presented asthma (2 intermittent, and 4 mild persist-
ent), as reported in Figure 1B. Among patients who de-
veloped asthma, AR worsened from intermittent to
mild persistent in 4/8, from mild persistent to
moderate-severe persistent in 3/8 and from intermit-
tent to moderate-severe persistent in 1/8.
SPT evaluation after 5 years showed the presence
of 42 new sensitizations in 34/104 patients (20 for
grass pollens, 2 for HDMs and 20 for tree pollens),
with no difference according to AR severity at
baseline.
Lung function evaluation, performed after 5 years
in patients who developed asthma, showed a not
significant changes both concerning FEV1 (95.5 ±
6.3% of predicted) and PEF (94.2 ± 5.4% of
predicted).Discussion
It is well known that AR and asthma are closely linked,
concerning clinical, functional, and immunological aspects.
In fact, nasal inflammation is associated with bronchial air-
flow limitation [5], as well as it has been demonstrated that
nasal eosinophil count is strongly related to eosinophil spu-
tum [6]. However, the possible impact of AR severity on
possible asthma onset is an issue that deserves note-
worthy attention. Therefore, this study aimed at investigat-
ing whether ARIA classification may be useful to predict
asthma onset in children with allergic rhinitis alone.
This study demonstrates that all children with
moderate-severe persistent AR developed asthma as
well as 33% of children with mild persistent AR. This
finding underlines the concept that persistence of AR
may be associated with progression from AR towards
asthma. The possible explanation might be that persist-
ent nasal inflammation may be associated with involve-
ment of lower airways both concerning mucosal
infiltration and lung function impairment [7,8]. There-
fore, the present study is consistent with previous surveys
that provided evidence of the close link between AR and
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young adults [9-13].
However, this study has the limitation that there was
no control group without AR, even though the AR sub-
classification according to ARIA criteria may allow to
consider the relevance of AR severity on the progres-
sion of the allergic reaction from the nose to the
bronchi.
In conclusion, all patients, who presented moderate-
to-severe persistent AR, developed asthma symptoms.
These results strongly indicate that the persistence of
AR may be an important factor that increases the risk
of asthma development in children.Competing interests
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